As a Latino advocacy group met with a federal regulator Tuesday to discuss their concerns about alleged abuses perpetrated by Herbalife (NYSE: HLF) against Latinos and others, hedge-fund manager Bill Ackman continued his efforts to portray the company as an illegal pyramid scheme. This time. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Bone Health Technologies Appoints Laura Yecies as Chief Executive Officer
April 07, 2021 12:11 ET | Source: Bone Health Technologies Bone Health Technologies San Francisco, California
SAN FRANCISCO, Calif., April 07, 2021 (GLOBE NEWSWIRE) Bone Health Technologies, a leading innovator of progressive new therapies for improving bone health, today announced the appointment of tech veteran Laura Yecies as Chief Executive Officer.
Yecies has successfully led multiple startups and top technology brands over her career of more than 20 years in Silicon Valley. A Harvard MBA with an MSFS from Georgetown, she is an experienced CEO, marketing executive and strategist with a proven ability to develop and market award-winning products, build teams, scale businesses, as well as profitably exit. Yecies was previously a Board Member of Bone Health Technologies, and will focus on expanding the team to execute strategy and accelerate growth.
Women Who Lead: Closing the medical research gap between men and women - San Francisco Business Times bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
email article
Adults with type 2 diabetes and cardiovascular disease who took empagliflozin (Jardiance) had lower total annual healthcare costs versus those who took other name brand diabetes medication, according to a retrospective analysis from Highmark and Boehringer Ingelheim.
The FDA warned against purchasing a slew of over-the-counter weight loss products, largely sold on Amazon and eBay, that contain dangerous unlabeled ingredients.
A joint task force from the National Kidney Foundation and American Society of Nephrology on reassessing inclusion of race in the diagnosis of kidney diseases is calling for commentary in January to help draft their final report.
In an analysis of nutrition and diet peer-reviewed studies published in the 10 most-cited journals in 2018, 13.4% of papers listed disclosures involving the food industry; the publication with the highest proportion was the